Skip to Main Content

Author Details

Mike Paulden
School of Public Health, University of Alberta
2009
71
23
Vardit Ravitsky (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38048985Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained.Value Health2024
38066357A Framework for the Fair Pricing of Medicines.Pharmacoeconomics2024
37279473Housing for vulnerable populations-identifying system cost implications: an analytic literature review.Health Promot Int2023
37752732We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.Health Econ Policy Law2023
33126829Quality of reporting of economic evaluations in rehabilitation research: a systematic review.Disabil Rehabil2022
35531945Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates.Med Decis Making2022
35553028Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups.Pharmacoeconomics2022
36201407Prediction of odds for emergency cesarean section: A secondary analysis of the CHILD term birth cohort study.PLoS One2022
35148951Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes.Can J Diabetes2022
34737062Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents.J Clin Epidemiol2022
34585359Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates.Pharmacoeconomics2022
33225423Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier.Pharmacoeconomics2021
33716210Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer.Gulf J Oncolog2021
33517512Modifying NICE's Approach to Equity Weighting.Pharmacoeconomics2021
33942459Noninvasive management of soft tissue disorders of the shoulder: A clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) collaboration.Eur J Pain2021
34089409Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial.Eur J Health Econ2021
33462758NICE's Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests.Pharmacoeconomics2021
31130722Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.Pharmacogenomics J2020
31840216One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.Pharmacoeconomics2020
33081576Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine.Med Decis Making2020
32812150Correction to: Calculating and Interpreting ICERs and Net Benefit.Pharmacoeconomics2020
32390067Calculating and Interpreting ICERs and Net Benefit.Pharmacoeconomics2020
32390066Why it's Time to Abandon the ICER.Pharmacoeconomics2020
32442926The health and financial impacts of a sugary drink tax across different income groups in Canada.Econ Hum Biol2020
31000411Appraising the cost-effectiveness of vaccines in the UK: Insights from the Department of Health Consultation on the revision of methods guidelines.Vaccine2019
31860422Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting.Can J Urol2019
31708058The Joint Committee on Vaccination and Immunisation's Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?Value Health2019
33282628Accounting for Timing when Assessing Health-Related Policies.J Benefit Cost Anal2019
31426930Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual Model.Value Health2019
30707486Non-pharmacological management of persistent headaches associated with neck pain: A clinical practice guideline from the Ontario protocol for traffic injury management (OPTIMa) collaboration.Eur J Pain2019
28573333Incorporating equity in economic evaluations: a multi-attribute equity state approach.Eur J Health Econ2018
30051268Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models.Pharmacoeconomics2018
29676787Turning High-Risk Individuals: An Economic Evaluation of Repositioning Frequency in Long-Term Care.J Am Geriatr Soc2018
29319484Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial.Can Urol Assoc J2018
27553208Determinants of Change in the Cost-effectiveness Threshold.Med Decis Making2017
28488257A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models.Pharmacoeconomics2017
28490259Recent amendments to NICE's value-based assessment of health technologies: implicitly inequitable?Expert Rev Pharmacoecon Outcomes Res2017
29037213Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.BMC Cancer2017
27943173Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine.Pharmacoeconomics2017
28062017Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process.J Obstet Gynaecol Can2017
27002519Cancer Drugs Fund 2.0: A Missed Opportunity?Pharmacoeconomics2016
26631759Which interventions are cost-effective for the management of whiplash-associated and neck pain-associated disorders? A systematic review of the health economic literature by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.Spine J2016
26476865Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment.Med Decis Making2016
26984876Management of neck pain and associated disorders: A clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.Eur Spine J2016
25412735Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.Pharmacoeconomics2015
26693110Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria.Springerplus2015
24599785Achieving allocative efficiency in healthcare: nice in theory, not so NICE in Practice?Pharmacoeconomics2014
26330894Turning for Ulcer Reduction (TURN) Study: An Economic Analysis.Ont Health Technol Assess Ser2014
27200565Nice's Proposed Value-Based Assessment of Health Technologies: Concerns of Inconsistent Consideration of Social Values.Value Health2014
25412736Objectivity and equity: clarity required. A response to Hill and Olson.Pharmacoeconomics2014
  • 1 - 50 of 71

Recommended Authors

Nathaniel Hendrix
Harvard T.H. Chan School of Public Health
Career Start Year 2017
Number of shared co-authors 0
Thomas Butt
UCL Institute of Ophthalmology, University College London
Career Start Year 2013
Number of shared co-authors 1
Seamus Kent
National Institute for Health and Care Excellence
Career Start Year 2013
Number of shared co-authors 0
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 0
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
James Buchanan
Health Economics Research Centre, University of Oxford
Career Start Year 2007
Number of shared co-authors 1
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
Craig R Ramsay
Health Services Research Unit, University of Aberdeen
Career Start Year 1998
Number of shared co-authors 0
Manuel Ridao
Instituto Aragones de Ciencias de la Salud (IIS Aragon)
Career Start Year 1997
Number of shared co-authors 0
Sarah Wordsworth
Health Economics Research Centre, University of Oxford
Career Start Year 1997
Number of shared co-authors 1
Maarten J IJzerman
Technical Medical Centre, University of Twente
Career Start Year 1997
Number of shared co-authors 0
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Andrew Walker
University of California San Diego
Career Start Year 1995
Number of shared co-authors 0
Mireille Goetghebeur
School of Public Health, Universite de Montreal 1
Career Start Year 1995
Number of shared co-authors 0
David O Meltzer
The University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Ben van Hout
University of Sheffield
Career Start Year 1993
Number of shared co-authors 0
David L Veenstra
University of Washington
Career Start Year 1992
Number of shared co-authors 0
Dana P Goldman
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Jason N Doctor
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 0
Anna N A Tosteson
Dartmouth Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Sean Tunis
Center for Evaluation of Value and Risk in Health, Tufts Medical Center
Career Start Year 1987
Number of shared co-authors 0
Joel Tsevat
Dell Medical School, University of Texas at Austin
Career Start Year 1987
Number of shared co-authors 0
John B Wong
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 0
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 0
Wendy J Ungar
The Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 8
Mark Helfand
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Theodore G Ganiats
university of california san diego
Career Start Year 1983
Number of shared co-authors 0
Stan N Finkelstein
University of Toronto
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Christopher McCabe
Queens University Belfast
Co-authored papers 18
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Co-authored papers 3
Susan D Horn
University of Utah
Co-authored papers 2
Jeff Round
Institute of Health Economics, University of Alberta
Co-authored papers 2
Tania Bubela
Simon Fraser University
Co-authored papers 1
Alessandro R Marcon
Faculty of Law and School of Public Health, University of Alberta
Co-authored papers 1
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Gabrielle Bertier
The Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Yann Joly
McGill University.
Co-authored papers 1
Meika Ellis
Health Law Institute, University of Alberta, University of Ottawa
Co-authored papers 1
Vardit Ravitsky (CM4AI)
The Hastings Center
Co-authored papers 1
Timothy Caulfield
Faculty of Law and School of Public Health, University of Alberta
Co-authored papers 1
Kalina Kamenova
Canadian Institute for Genomics and Society.
Co-authored papers 1
George Tomlinson
University Health Network
Co-authored papers 1
Stanislav Birko
UNIVERSITY OF MONTREAL
Co-authored papers 1
Fiona A Miller
Institute of Health Policy, University of Toronto
Co-authored papers 1
Blake Murdoch
University of Alberta
Co-authored papers 1
Ubaka Ogbogu
University of Alberta
Co-authored papers 1
Zubin Master
Biomedical Ethics Research Program & Center for Regenerative Medicine, Mayo Clinic
Co-authored papers 1
Palmira Granados Moreno
McGill University
Co-authored papers 1
Jeremy De Beer
University of Ottawa
Co-authored papers 1
Fran??ois Rousseau
Universite Laval
Co-authored papers 1
Sarah E Ali-Khan
McGill University
Co-authored papers 1
Charles Dupras
School of Public Health, University of Montreal
Co-authored papers 1
Release 1.2